Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR.

Ngetsa C. et al, (2023), PloS one, 18

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

Tegally H. et al, (2022), Science, 378

Amplicon Sequencing as a Potential Surveillance Tool for Complexity of Infection and Drug Resistance Markers in Plasmodium falciparum Asymptomatic Infections.

Wamae K. et al, (2022), The Journal of infectious diseases, 226, 920 - 927

Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya.

Orangi S. et al, (2022), BMJ global health, 7

Genomic Epidemiology of SARS-CoV-2 in Seychelles, 2020-2021.

Morobe JM. et al, (2022), Viruses, 14

Maintenance of high temporal Plasmodium falciparum genetic diversity and complexity of infection in asymptomatic and symptomatic infections in Kilifi, Kenya from 2007 to 2018.

Kimenyi KM. et al, (2022), Malaria journal, 21

Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: A retrospective genomic study.

Agoti CN. et al, (2022), eLife, 11

Targeted Amplicon Deep Sequencing for Monitoring Antimalarial Resistance Markers in Western Kenya

Osoti V. et al, (2022), Antimicrobial Agents and Chemotherapy, 66

Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya

Nyagwange J. et al, (2022), Wellcome Open Research, 7, 69 - 69

Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations.

Nyagwange J. et al, (2022), Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 146

Optimization of the SARS-CoV-2 ARTIC Network V4 Primers and Whole Genome Sequencing Protocol.

Lambisia AW. et al, (2022), Frontiers in medicine, 9

Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya.

Etyang AO. et al, (2022), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 74, 288 - 293

COVID-19 transmission dynamics underlying epidemic waves in Kenya.

Brand SPC. et al, (2021), Science (New York, N.Y.), 374, 989 - 994

A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa

Ndwiga L. et al, (2021), International Journal for Parasitology: Drugs and Drug Resistance, 16, 155 - 161

Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya.

Githinji G. et al, (2021), Nature communications, 12

Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya.

Kagucia EW. et al, (2021), Open forum infectious diseases, 8

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.

Adetifa IMO. et al, (2021), Nature communications, 12

The Plasmodium falciparum Rh5 invasion protein complex reveals an excess of rare variant mutations.

Ndwiga L. et al, (2021), Malaria journal, 20

Detection of SARS-CoV-2 variant 501Y.V2 in Comoros Islands in January 2021.

N Agoti C. et al, (2021), Wellcome open research, 6

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors.

Uyoga S. et al, (2021), Science (New York, N.Y.), 371, 79 - 82

Load More

Include forthcoming?